Actinogen Free Cash Flow vs Depreciation Analysis

ACW Stock

0.03 0 3.85%

Actinogen Medical financial indicator trend analysis is way more than just evaluating Actinogen Medical prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Actinogen Medical is a good investment. Please check the relationship between Actinogen Medical Free Cash Flow and its Depreciation accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Actinogen Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Free Cash Flow vs Depreciation

Free Cash Flow vs Depreciation Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Actinogen Medical Free Cash Flow account and Depreciation. At this time, the significance of the direction appears to have strong contrarian relationship.

The correlation between Actinogen Medical's Free Cash Flow and Depreciation is -0.53. Overlapping area represents the amount of variation of Free Cash Flow that can explain the historical movement of Depreciation in the same time period over historical financial statements of Actinogen Medical, assuming nothing else is changed. The correlation between historical values of Actinogen Medical's Free Cash Flow and Depreciation is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Free Cash Flow of Actinogen Medical are associated (or correlated) with its Depreciation. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Depreciation has no effect on the direction of Free Cash Flow i.e., Actinogen Medical's Free Cash Flow and Depreciation go up and down completely randomly.

Correlation Coefficient

-0.53

Relationship Direction	Negative
Relationship Strength	Very Weak

View All Relationships

Free Cash Flow

The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.

Depreciation

Depreciation indicates how much of Actinogen Medical value has been used up. For tax purposes Actinogen Medical can deduct the cost of the tangible assets it purchases as business expenses. However, Actinogen Medical must depreciate these assets in accordance with IRS rules about how and when the deduction may be taken, and how long it will last. The systematic allocation of the cost of a tangible asset over its useful life.

Most indicators from Actinogen Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Actinogen Medical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Actinogen Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Selling General Administrative is likely to drop to about 1.3 M in 2024. Issuance Of Capital Stock is likely to drop to about 11.5 M in 2024

	2021	2022	2023	2024 (projected)
Total Revenue	3.6M	4.9M	9.9M	10.4M
Depreciation And Amortization	400.7K	405.6K	334.7K	239.4K

Total Revenue Depreciation And Amortization

Actinogen Medical fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Cash	Net Receivables	Total Liab	Common Stock	Property Plant Equipment	Other Current Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Non Current Assets Total	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Inventory	Other Stockholder Equity	Property Plant And Equipment Gross	Total Current Assets	Intangible Assets	Non Currrent Assets Other	Net Tangible Assets	Short Term Investments
Total Assets		0.7	0.79	1.0	0.82	0.74	0.81	0.88	0.3	0.51	0.51	-0.85	-0.81	0.65	0.64	0.86	0.93	0.86	0.62	-0.85	0.55	0.97	0.36	-0.32	0.94	-0.74
Other Current Liab	0.7		0.86	0.67	0.47	0.85	0.92	0.92	0.33	0.43	0.63	-0.52	-0.95	0.49	0.15	0.45	0.86	0.93	0.68	-0.86	0.7	0.76	-0.08	0.11	0.61	-0.76
Total Current Liabilities	0.79	0.86		0.76	0.57	0.75	0.99	0.9	0.1	0.6	0.33	-0.59	-0.89	0.86	0.35	0.61	0.83	0.91	0.76	-0.83	0.4	0.81	0.1	-0.16	0.72	-0.74
Total Stockholder Equity	1.0	0.67	0.76		0.83	0.72	0.78	0.87	0.31	0.5	0.51	-0.85	-0.78	0.63	0.65	0.87	0.92	0.84	0.59	-0.83	0.55	0.97	0.38	-0.33	0.94	-0.72
Cash	0.82	0.47	0.57	0.83		0.38	0.57	0.66	0.39	0.14	0.41	-0.98	-0.61	0.53	0.42	0.97	0.73	0.65	0.25	-0.58	0.43	0.83	0.21	-0.29	0.94	-0.65
Net Receivables	0.74	0.85	0.75	0.72	0.38		0.8	0.9	0.2	0.64	0.63	-0.46	-0.89	0.43	0.19	0.39	0.8	0.87	0.8	-0.84	0.7	0.8	0.01	0.24	0.58	-0.62
Total Liab	0.81	0.92	0.99	0.78	0.57	0.8		0.93	0.15	0.55	0.41	-0.6	-0.94	0.77	0.33	0.61	0.87	0.95	0.77	-0.87	0.48	0.83	0.08	-0.12	0.72	-0.77
Common Stock	0.88	0.92	0.9	0.87	0.66	0.9	0.93		0.25	0.52	0.58	-0.71	-0.99	0.61	0.3	0.67	0.93	0.99	0.72	-0.91	0.65	0.93	0.08	0.03	0.8	-0.77
Property Plant Equipment	0.3	0.33	0.1	0.31	0.39	0.2	0.15	0.25		0.13	0.86	-0.35	-0.26	-0.09	0.13	0.29	0.48	0.24	-0.06	-0.28	0.8	0.29	0.04	0.05	0.41	-0.56
Other Current Assets	0.51	0.43	0.6	0.5	0.14	0.64	0.55	0.52	0.13		0.31	-0.19	-0.48	0.61	0.38	0.24	0.52	0.49	0.75	-0.51	0.35	0.5	0.15	-0.08	0.39	-0.42
Property Plant And Equipment Net	0.51	0.63	0.33	0.51	0.41	0.63	0.41	0.58	0.86	0.31		-0.42	-0.58	-0.04	0.08	0.31	0.68	0.55	0.29	-0.55	0.99	0.55	-0.04	0.25	0.49	-0.66
Net Debt	-0.85	-0.52	-0.59	-0.85	-0.98	-0.46	-0.6	-0.71	-0.35	-0.19	-0.42		0.66	-0.5	-0.38	-0.96	-0.75	-0.7	-0.35	0.6	-0.45	-0.88	-0.16	0.22	-0.94	0.64
Retained Earnings	-0.81	-0.95	-0.89	-0.78	-0.61	-0.89	-0.94	-0.99	-0.26	-0.48	-0.58	0.66		-0.59	-0.19	-0.6	-0.9	-0.99	-0.7	0.88	-0.66	-0.87	0.02	-0.11	-0.73	0.77
Accounts Payable	0.65	0.49	0.86	0.63	0.53	0.43	0.77	0.61	-0.09	0.61	-0.04	-0.5	-0.59		0.46	0.61	0.57	0.63	0.6	-0.58	0.02	0.61	0.24	-0.39	0.64	-0.57
Non Current Assets Total	0.64	0.15	0.35	0.65	0.42	0.19	0.33	0.3	0.13	0.38	0.08	-0.38	-0.19	0.46		0.52	0.52	0.28	0.26	-0.47	0.07	0.45	0.71	-0.84	0.53	-0.4
Cash And Short Term Investments	0.86	0.45	0.61	0.87	0.97	0.39	0.61	0.67	0.29	0.24	0.31	-0.96	-0.6	0.61	0.52		0.74	0.66	0.37	-0.59	0.34	0.86	0.27	-0.39	0.96	-0.64
Common Stock Total Equity	0.93	0.86	0.83	0.92	0.73	0.8	0.87	0.93	0.48	0.52	0.68	-0.75	-0.9	0.57	0.52	0.74		0.93	0.62	-0.9	0.72	0.92	0.24	-0.17	0.86	-0.87
Common Stock Shares Outstanding	0.86	0.93	0.91	0.84	0.65	0.87	0.95	0.99	0.24	0.49	0.55	-0.7	-0.99	0.63	0.28	0.66	0.93		0.71	-0.9	0.63	0.91	0.06	0.03	0.78	-0.78
Inventory	0.62	0.68	0.76	0.59	0.25	0.8	0.77	0.72	-0.06	0.75	0.29	-0.35	-0.7	0.6	0.26	0.37	0.62	0.71		-0.66	0.36	0.68	-0.01	0.0	0.47	-0.57
Other Stockholder Equity	-0.85	-0.86	-0.83	-0.83	-0.58	-0.84	-0.87	-0.91	-0.28	-0.51	-0.55	0.6	0.88	-0.58	-0.47	-0.59	-0.9	-0.9	-0.66		-0.61	-0.84	-0.4	0.15	-0.72	0.74
Property Plant And Equipment Gross	0.55	0.7	0.4	0.55	0.43	0.7	0.48	0.65	0.8	0.35	0.99	-0.45	-0.66	0.02	0.07	0.34	0.72	0.63	0.36	-0.61		0.6	-0.06	0.28	0.52	-0.68
Total Current Assets	0.97	0.76	0.81	0.97	0.83	0.8	0.83	0.93	0.29	0.5	0.55	-0.88	-0.87	0.61	0.45	0.86	0.92	0.91	0.68	-0.84	0.6		0.19	-0.13	0.94	-0.73
Intangible Assets	0.36	-0.08	0.1	0.38	0.21	0.01	0.08	0.08	0.04	0.15	-0.04	-0.16	0.02	0.24	0.71	0.27	0.24	0.06	-0.01	-0.4	-0.06	0.19		-0.64	0.26	-0.14
Non Currrent Assets Other	-0.32	0.11	-0.16	-0.33	-0.29	0.24	-0.12	0.03	0.05	-0.08	0.25	0.22	-0.11	-0.39	-0.84	-0.39	-0.17	0.03	0.0	0.15	0.28	-0.13	-0.64		-0.29	0.14
Net Tangible Assets	0.94	0.61	0.72	0.94	0.94	0.58	0.72	0.8	0.41	0.39	0.49	-0.94	-0.73	0.64	0.53	0.96	0.86	0.78	0.47	-0.72	0.52	0.94	0.26	-0.29		-0.73
Short Term Investments	-0.74	-0.76	-0.74	-0.72	-0.65	-0.62	-0.77	-0.77	-0.56	-0.42	-0.66	0.64	0.77	-0.57	-0.4	-0.64	-0.87	-0.78	-0.57	0.74	-0.68	-0.73	-0.14	0.14	-0.73

Click cells to compare fundamentals

Actinogen Medical Account Relationship Matchups

Actinogen Medical fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	11.9M	18.4M	23.3M	15.2M	21.3M	22.4M
Other Current Liab	611.0K	291.7K	502.5K	613.2K	699.1K	734.0K
Total Current Liabilities	743.8K	755.1K	1.5M	1.8M	1.4M	1.4M
Total Stockholder Equity	10.9M	17.5M	21.7M	13.4M	19.7M	20.7M
Cash	5.0M	13.4M	16.4M	8.5M	9.5M	5.2M
Net Receivables	2.7M	1.5M	3.9M	3.9M	9.3M	9.8M
Total Liab	1.0M	920.3K	1.6M	1.8M	1.6M	1.7M
Common Stock	47.9M	60.1M	76.9M	78.7M	100.0M	105.0M
Other Current Assets	60.2K	90.0K	104.6K	344.5K	294.2K	309.0K
Net Debt	(4.7M)	(13.2M)	(16.2M)	(8.4M)	(9.1M)	(8.7M)
Retained Earnings	(44.5M)	(48.4M)	(57.9M)	(68.7M)	(81.7M)	(77.6M)
Accounts Payable	46.8K	392.2K	898.7K	1.1M	597.2K	353.5K
Non Current Assets Total	3.8M	3.3M	2.9M	2.5M	2.4M	2.6M
Cash And Short Term Investments	5.0M	13.4M	16.4M	8.5M	9.5M	6.3M
Common Stock Shares Outstanding	1.2B	1.5B	1.8B	1.9B	2.2B	2.3B
Liabilities And Stockholders Equity	11.9M	18.4M	23.3M	15.2M	21.3M	11.2M
Other Stockholder Equity	(6.8M)	(1.9M)	(6.3M)	(7.2M)	(10.5M)	(10.0M)
Total Current Assets	8.2M	15.1M	20.4M	12.7M	18.9M	19.8M
Accumulated Other Comprehensive Income	7.5M	7.8M	9.1M	10.6M	1.4M	1.3M
Intangible Assets	3.3M	3.0M	2.7M	2.4M	2.1M	2.7M
Non Currrent Assets Other	(3.7M)	(3.3M)	(2.9M)	(2.5M)	(1.0)	(1.05)
Net Tangible Assets	7.5M	14.4M	19.0M	11.0M	12.6M	10.9M
Net Invested Capital	10.9M	17.5M	21.7M	13.4M	19.7M	17.3M
Cash And Equivalents	3.6M	7.1M	12.1M	7.2M	8.3M	7.8M
Net Working Capital	7.4M	14.3M	18.9M	10.9M	17.5M	13.5M
Capital Stock	47.9M	60.1M	76.9M	78.7M	100.0M	75.5M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Actinogen Stock Analysis

When running Actinogen Medical's price analysis, check to measure Actinogen Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Actinogen Medical is operating at the current time. Most of Actinogen Medical's value examination focuses on studying past and present price action to predict the probability of Actinogen Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Actinogen Medical's price. Additionally, you may evaluate how the addition of Actinogen Medical to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC